Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-22-010379

CHIEF ACCOUNTING OFFICER gave up 52 shares (to pay taxes)

  • CHIEF ACCOUNTING OFFICER acquired 175 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Megna Michael R CHIEF ACCOUNTING OFFICER 2022-10-04 Option exercise +175 7,466 D
Megna Michael R CHIEF ACCOUNTING OFFICER 2022-10-04 Shares withheld for taxes −52 $14.23 $740 7,414 D
Derivatives
Megna Michael R CHIEF ACCOUNTING OFFICER 2022-10-04 Option exercise · Restricted Share Unit −175 525 D
Loading xslF345X03/form4-10062022_011035.xml…